Evidence map›Paper›PMID 21902835›Full record

Trial reportBMC medical genetics2011

Effect of heme oxygenase-1 polymorphisms on lung function and gene expression.

Goh Tanaka, Farzian Aminuddin, Loubna Akhabir, Jian-Qing He, Karey Shumansky, John E Connett, Nicholas R Anthonisen, Raja T Abboud, Peter D Paré, Andrew J Sandford

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in BMC medical genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. The Role of Heme Oxygenase-1 Promoter Polymorphisms in Perinatal Disease.International journal of environmental research and public health · 2021
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The role of gene-ambient air pollution interactions in paediatric asthma.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation.Translational research : the journal of laboratory and clinical medicine · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Goh TanakaUBC James Hogg Research Center, Providence Heart + Lung Institute, St, Paul's Hospital, Vancouver, B.C., Canada.
Farzian Aminuddin
Loubna Akhabir
Jian-Qing He
Karey Shumansky
John E Connett
Nicholas R Anthonisen
Raja T Abboud
Peter D Paré
Andrew J Sandford
St. Paul's Hospital · CAUniversity of Manitoba · CAUniversity of Minnesota · USVancouver General Hospital · CA

Funding

REMODELING OF HUMAN AIRWAYS IN DISEASER01HL064068 · NHLBI · UNIVERSITY OF BRITISH COLUMBIA · PI PARE, PETER DAVID · 1999 to 2002
$600k
EARLY INTERVENTION/CHRONIC OBSTRUCTIVE PULMONARY DISEASEN01HR046002 · HR · UNIVERSITY OF MINNESOTA TWIN CITIES · PI CONNETT, JOHN E · 1985 to 1998
–
Canadian Institutes of Health ResearchNHLBI NIH HHS 5R01HL064068-04NHLBI NIH HHS N01-HR-46002
6 · The paper itself

Abstract

backgroundOxidative stress induced by smoking is considered to be important in the pathogenesis of Chronic Obstructive Pulmonary Disease (COPD). Heme oxygenase-1 (HMOX1) is an essential enzyme in heme catabolism that is induced by oxidative stress and may play a protective role as an antioxidant in the lung. We determined whether HMOX1 polymorphisms were associated with lung function in COPD patients and whether the variants had functional effects.

methodsWe genotyped five single nucleotide polymorphisms (SNPs) in the HMOX1 gene in Caucasians who had the fastest (n = 278) and the slowest (n = 304) decline of FEV1 % predicted, selected from smokers in the NHLBI Lung Health Study. These SNPs were also studied in Caucasians with the lowest (n = 535) or the highest (n = 533) baseline lung function. Reporter genes were constructed containing three HMOX1 promoter polymorphisms and the effect of these polymorphisms on H2O2 and hemin-stimulated gene expression was determined. The effect of the HMOX1 rs2071749 SNP on gene expression in alveolar macrophages was investigated.

resultsWe found a nominal association (p = 0.015) between one intronic HMOX1 SNP (rs2071749) and lung function decline but this did not survive correction for multiple comparisons. This SNP was in perfect linkage disequilibrium with rs3761439, located in the promoter of HMOX1. We tested rs3761439 and two other putatively functional polymorphisms (rs2071746 and the (GT)n polymorphism) in reporter gene assays but no significant effects on gene expression were found. There was also no effect of rs2071749 on HMOX1 gene expression in alveolar macrophages.

conclusionsWe found no association of the five HMOX1 tag SNPs with lung function decline and no evidence that the three promoter polymorphisms affected the regulation of the HMOX1 gene.

Indexed as

Polymorphism, Single NucleotideAdultBase SequenceDNA PrimersFemaleForced Expiratory VolumeGene ExpressionGenome-Wide Association StudyHaplotypesHeme Oxygenase-1HumansLungMacrophages, AlveolarMaleMiddle AgedPromoter Regions, GeneticDNA PrimersHeme Oxygenase-1HMOX1 protein, human

Identifiers

PMID21902835
PMCPMC3180266
OpenAlexW2090225469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.